CD8A and neoplasm: The number of tumor specific CD8+IFN-γ+ T cells was greatly increased when mice were vaccinated with RPS3-activated wild type DCs pulsed with E7, but not with RSP3 treated TLR4−/− DCs pulsed with E7.